H.I.G. BioVentures II Closes on $268M
April 11, 2012- Share:
The fund will invest in product development healthcare companies in North America, with a focus on pharmaceuticals, medical devices and diagnostics. H.I.G. BioVentures invests between $3 million and $40 million per company over the life of an investment.
Fund Name:
General Partner
Miami, FL
Venture Capital
Closed
$268 million
$250 million
- Share:
-
-
-
-